Seòmar agus comataidhean

Questions and answers

Parliamentary questions can be asked by any MSP to the Scottish Government or the Scottish Parliamentary Corporate Body. The questions provide a means for MSPs to get factual and statistical information.

Written questions must be answered within 10 working days (20 working days during recess)
Other questions such as Topical, Portfolio, General and First Minister's Question Times are taken in the Chamber

Urgent Questions aren't included in the Question and Answers search. There is a SPICe fact sheet listing Urgent and emergency questions.

Find out more about parliamentary questions

Criathragan Hide all filters

Displaying 9128 questions Show Answers

Order by |

Question reference: S5O-04232

Asked by: Jackie Baillie, MSP for Dumbarton, Scottish Labour
Date lodged: Thursday, 27 February 2020
Current Status: Taken in the Chamber on 5 March 2020

To ask the Scottish Parliamentary Corporate Body whether it will uprate Members' staff cost provision in line with the Scottish Government uprating of 3%.

Question reference: S5F-03958

Asked by: Jackie Baillie, MSP for Dumbarton, Scottish Labour
Date lodged: Monday, 17 February 2020
Current Status: Taken in the Chamber on 20 February 2020

To ask the First Minster what action the Scottish Government is taking to prepare the NHS to deal with coronavirus.

Question reference: S5W-27109

Asked by: Jackie Baillie, MSP for Dumbarton, Scottish Labour
Date lodged: Thursday, 23 January 2020
Current Status: Answered by Jeane Freeman on 6 February 2020

To ask the Scottish Government what (a) communication it has had with NHS boards and (b) action it is taking regarding the need for people with Parkinson’s to get their essential medication on time when they are in hospital.

It is for Boards to ensure that operational processes are in place to safeguard those patients with medicine regimes are adhered to when they are in hospital.

The Scottish Government continues to work with NHS Boards in transforming hospital pharmacy services as set out in Achieving Excellence in Pharmaceutical Care (AEiPC), published in August 2017.

AEiPC sets out nine commitments and complimentary actions to transform the role of pharmacy across all areas of pharmacy practice, increase capacity, and offer the best person-centred care. It sets out the priorities, commitments and actions for improving and integrating pharmacy and pharmacy services in Scotland.

The AEiPC Advisory Group was established to take forward the nine commitments and supporting actions. Key stakeholders on this group, include representatives from NHS Board Directors of Pharmacy, Community Pharmacy Scotland, the Royal Pharmaceutical Society, Acute Services Lead Pharmacists, Pharmacy Technicians, and the Scottish Pharmacy Clinical Leadership Fellows.

Question reference: S5W-27111

Asked by: Jackie Baillie, MSP for Dumbarton, Scottish Labour
Date lodged: Thursday, 23 January 2020
Current Status: Answered by Jeane Freeman on 6 February 2020

To ask the Scottish Government whether it will advise NHS boards to ensure that (a) clinical governance and (b) patient safety teams consider and address Parkinson’s medication management in hospitals.

Effective medications management is particularly relevant in Parkinson’s administration as complications can develop if medication is not taken on time. Ensuring patients receive their medication on time when in hospital is a fundamental aspect of good quality care, and we expect NHS Boards to follow the professional guidance, published in January 2019 by the Royal Pharmaceutical Society and the Royal College of Nursing, on ‘the Administration of Medicines in Healthcare Settings’.

We will work with Parkinson’s UK and healthcare providers, including the NHS, to support better awareness and education amongst healthcare professionals, and we welcome the training materials that have been produced by Parkinson’s UK to facilitate this education.

Healthcare Improvement Scotland (HIS) shares learning and good practice across NHS Scotland through the Area Drug and Therapeutics Committee Collaborative. Through this Collaborative, NHS Ayrshire and Arran has shared its experience in utilising the Hospital Electronic Prescribing and Medicines Administration (HEPMA) to optimise Parkinson’s medicines with other Boards.

All of that noted we remain open to what more can be done to support patients.

Question reference: S5W-27113

Asked by: Jackie Baillie, MSP for Dumbarton, Scottish Labour
Date lodged: Thursday, 23 January 2020
Current Status: Answered by Jeane Freeman on 5 February 2020

To ask the Scottish Government which NHS boards have a self-administration of medicines policy that enables people with Parkinson’s to take their own medication if they are able to do so.

In healthcare settings, including hospitals, organisational policies will define who can administer medicines, or the appropriate delegation of the administration of medicines, within that setting. This should include a policy for self-administration of medicines.

Ideally, patients should maintain responsibility for the administration of some or all of their medicines, during a stay in the healthcare setting, unless a risk assessment indicates otherwise.

Registered healthcare professionals who administer medicines, or when appropriate delegate the administration of medicines, are accountable for their actions, non-actions and omissions, and exercise professionalism and professional judgement at all times. They would be expected to meet their own professional and regulatory standards and guidance. Non-registered healthcare professionals are appropriately trained, assessed as competent and meet relevant organisational guidance on medicines administration.

Before administration, the person administering the medicine must have an overall understanding of the medicine being administered and seek advice if necessary from a prescriber or a pharmacy professional.

Question reference: S5W-27119

Asked by: Jackie Baillie, MSP for Dumbarton, Scottish Labour
Date lodged: Thursday, 23 January 2020
Current Status: Answered by Jeane Freeman on 5 February 2020

To ask the Scottish Government how many adverse incidents relating to Parkinson’s medication have been reported in each NHS board in each of the last three years.

This information is not held centrally by the Scottish Government but should be held by individual NHS Boards. Furthermore, the Medicines and Healthcare products Regulatory Agency monitors reports of suspected adverse drug reactions submitted by healthcare professionals, patients and carers through the Yellow Card scheme.

Rose Marie Parr, Chief Pharmaceutical Officer has agreed to meet Parkinson’s UK to discuss this and although a meeting has been offered, no response has yet been received from Parkinson’s UK.

Question reference: S5W-27107

Asked by: Jackie Baillie, MSP for Dumbarton, Scottish Labour
Date lodged: Thursday, 23 January 2020
Current Status: Answered by Jeane Freeman on 4 February 2020

To ask the Scottish Government which NHS boards have (a) open visiting and (b) extended visiting hours in their hospitals.

NHS Scotland is now taking a person-centred approach to visiting, with all boards having implemented in full or in part.

The 2018-19 Programme for Government contained a commitment to have flexible visiting in place across NHS Scotland by 2020.

A person-centred approach to visiting is underpinned by three principles:

-the absence of set visiting times

-a conversation supported by a reliable process for the person or patient to designate those people that matter most to them

-how they would like them involved in their care

We are monitoring NHS Boards’ progress towards full implementation. Those boards who have yet to implement in full – Ayrshire and Arran, Greater Glasgow and Clyde, Forth Valley and Tayside- have told us they will have done so by March this year.

The absence of set visiting times does not mean family and carer presence is unmanaged. For example, there may be times in multiple occupancy areas when families are asked to leave to allow personal care for another patient in the area to take place.

Question reference: S5W-27116

Asked by: Jackie Baillie, MSP for Dumbarton, Scottish Labour
Date lodged: Thursday, 23 January 2020
Current Status: Answered by Jeane Freeman on 4 February 2020

To ask the Scottish Government which NHS boards currently use Hospital Electronic Prescribing and Medicines Administration (HEPMA) systems to ensure that people with Parkinson’s receive their medication on time when they are in hospital, and what steps it is taking to ensure that all NHS boards prioritise their use for this purpose.

Hospital Electronic Prescribing and Medicines Administration (HEPMA) is being rolled out across Scotland and has already been implemented in four NHS Boards. HEPMA systems do not automatically ensure that people get their medication on time but HEPMA can enable and support Boards locally to design new processes and ways of working for patient care. NHS Ayrshire & Arran and NHS Dumfries & Galloway utilise a HEPMA report developed in Ayrshire & Arran to monitor the timeliness of administration for Parkinson’s medication.

The national Hospital Electronic Prescribing and Medicines Administration (HEPMA) Oversight Board, who monitor all benefits from HEPMA implementations, will share the learning from the NHS Ayrshire & Arran pilot to support best practice and drive improvement across Scotland.

Question reference: S5W-27114

Asked by: Jackie Baillie, MSP for Dumbarton, Scottish Labour
Date lodged: Thursday, 23 January 2020
Current Status: Answered by Jeane Freeman on 4 February 2020

To ask the Scottish Government which NHS boards have fully implemented Hospital Electronic Prescribing and Medicines Administration (HEPMA) to date, and when each remaining board is expected to do so.

Question reference: S5W-27118

Asked by: Jackie Baillie, MSP for Dumbarton, Scottish Labour
Date lodged: Thursday, 23 January 2020
Current Status: Answered by Jeane Freeman on 4 February 2020

To ask the Scottish Government how many inpatient Parkinson’s medication errors have been recorded in each NHS board in each of the last three years.